Precigen PGEN
$4.21 +$0.05 (+1.20%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.24 +0.61%
Open$4.16
Prev close$4.16
Day range$4.07 – $4.36
Volume6.07M
Market cap$1.51B
P/E (TTM)38.3
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$74.15M+2,437.6% YoY
Operating profit$38.65M+212.1% YoY
Net profit$35.77M+124.4% YoY
Diluted EPS$0.08+107.5% YoY
Free cash flow$11.45M+138.9% YoY
Operating cash flow$11.88M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin91.4%
Operating margin21.4%
Net margin15.6%
Return on equity38.8%
Return on assets12.7%
Return on invested capital20.9%
Current ratio5.58
Liabilities / assets60.5%
Cash & investments$46.07M
Total debt$97.47M
Net cash (debt)-$51.40M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $74.15M | $54.98M | $23.25M | $9.68M | $4.57M |
| Total Operating Revenue | $74.15M | $54.98M | $23.25M | $9.68M | $4.57M |
| Cost of Revenue | $6.51M | $2.81M | $2.56M | $4.82M | $1.60M |
| Gross Profit | $67.64M | $52.17M | $20.69M | $4.86M | $2.97M |
| Operating Expense | $28.99M | $29.53M | $26.69M | $111.46M | $24.64M |
| Selling and Admin Expenses | $22.36M | $22.25M | $21.05M | $70.13M | $17.65M |
| Research & Development | $6.63M | $7.28M | $5.64M | $41.33M | $6.99M |
| Operating Profit | $38.65M | $22.64M | -$5.99M | -$106.60M | -$21.67M |
| Net Non-Operating Interest Income (Expense) | -$2.67M | -$2.59M | -$2.23M | -$652,000.00 | -$1.90M |
| Non-Operating Interest Income | $323,000.00 | $366,000.00 | $683,000.00 | $3.22M | $1.07M |
| Non-Operating Interest Expense | $3.00M | $2.95M | $2.91M | $3.87M | $2.96M |
| Other Income (Expense) | -$11,000.00 | $16,000.00 | $290,000.00 | -$143.39M | $60,000.00 |
| Special Income (Charges) | $0.00 | $0.00 | – | -$3.91M | $0.00 |
| -Less:Impairment of Capital Assets | $0.00 | $0.00 | – | $3.91M | $0.00 |
| Other Non-Operating Income (Expenses) | -$11,000.00 | $16,000.00 | $290,000.00 | $43,000.00 | $60,000.00 |
| Pretax Profit | $35.97M | $20.07M | -$7.93M | -$250.64M | -$23.50M |
| Tax | $200,000.00 | $0.00 | $0.00 | $3,000.00 | $0.00 |
| Net Profit | $35.77M | $20.07M | -$7.93M | -$250.64M | -$23.50M |
| Profit from Continuing Operations | $35.77M | $20.07M | -$7.93M | -$250.64M | -$23.50M |
| Net Income to Parent Company | $35.77M | $20.07M | -$7.93M | -$250.64M | -$23.50M |
| Net Income to Common Stockholders | $35.77M | $20.07M | -$7.93M | -$429.64M | -$23.50M |
| Basic EPS | $0.10 | $0.06 | -$0.02 | -$1.37 | -$0.01 |
| Diluted EPS | $0.08 | $0.05 | -$0.02 | -$1.37 | -$0.01 |
| Gain on Sale of Security | – | – | – | -$139.52M | $0.00 |
| Preferred Stock Dividends | – | – | – | $179.00M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $212.10M | $170.30M | $138.63M | $155.51M | $155.51M |
| Total Current Assets | $171.76M | $134.38M | $101.67M | $115.24M | $115.24M |
| Cash and Cash Equivalents & Short-Term Investments | $46.07M | $38.21M | $56.25M | $97.86M | $97.86M |
| -Cash and Cash Equivalents | $14.96M | $16.33M | $7.48M | $30.23M | $30.23M |
| -Short Term Investments | $31.11M | $21.88M | $48.77M | $67.62M | $67.62M |
| Receivables | $96.62M | $72.04M | $26.71M | $4.36M | $4.36M |
| -Accounts Receivable | $96.49M | $71.87M | $26.40M | $3.92M | $3.92M |
| -Other Receivables | $133,000.00 | $178,000.00 | $302,000.00 | $446,000.00 | $446,000.00 |
| Inventory | $22.92M | $20.25M | $14.73M | $9.58M | $9.58M |
| Other Current Assets | $6.16M | $3.89M | $4.00M | $3.43M | $3.43M |
| Total Non-Current Assets | $40.34M | $35.91M | $36.96M | $40.27M | $40.27M |
| Net PPE | $17.27M | $16.87M | $17.52M | $18.36M | $18.36M |
| -Gross PPE | $43.44M | $42.25M | $42.12M | $42.19M | $42.19M |
| -Accumulated Depreciation | -$26.18M | -$25.38M | -$24.60M | -$23.82M | -$23.82M |
| Investments and Advances | $4.91M | $490,000.00 | $489,000.00 | $2.51M | $2.51M |
| -Available for Sale Securities | $4.91M | $490,000.00 | $489,000.00 | $2.51M | $2.51M |
| Goodwill and Other Intangible Assets | $17.46M | $17.78M | $18.10M | $18.41M | $18.41M |
| -Goodwill | $15.23M | $15.23M | $15.23M | $15.23M | $15.23M |
| -Other Intangible Assets | $2.23M | $2.55M | $2.86M | $3.18M | $3.18M |
| Other Non-Current Assets | $704,000.00 | $771,000.00 | $852,000.00 | $982,000.00 | $982,000.00 |
| Total Liabilities | $128.31M | $126.72M | $118.39M | $134.59M | $134.59M |
| Total Current Liabilities | $30.79M | $29.35M | $21.10M | $37.31M | $37.31M |
| Payables | $7.06M | $5.30M | $2.59M | $11.99M | $11.99M |
| -Accounts Payable | $7.06M | $5.30M | $2.59M | $11.99M | $11.99M |
| Current Accrued Expenses | $14.57M | $16.21M | $12.48M | $13.47M | $13.47M |
| Short-Term Debt and Capital Lease Obligation | $1.14M | $1.06M | $1.07M | $1.14M | $1.14M |
| -Current Capital Lease Obligation | $1.14M | $1.06M | $1.07M | $1.14M | $1.14M |
| Current Deferred Liabilities | $174,000.00 | $284,000.00 | $410,000.00 | $517,000.00 | $517,000.00 |
| Total Non-Current Liabilities | $97.52M | $97.37M | $97.29M | $97.29M | $97.29M |
| Long Term Debt and Capital Lease Obligation | $97.47M | $97.29M | $97.18M | $97.15M | $97.15M |
| -Long Term Debt | $94.26M | $93.88M | $93.52M | $93.17M | $93.17M |
| -Long Term Capital Lease Obligation | $3.22M | $3.41M | $3.66M | $3.98M | $3.98M |
| Other Non-Current Liabilities | $48,000.00 | $77,000.00 | $106,000.00 | $134,000.00 | $134,000.00 |
| Total Equity | $83.79M | $43.58M | $20.24M | $20.91M | $20.91M |
| Stockholders' Equity | $83.79M | $43.58M | $20.24M | $20.91M | $20.91M |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.38B | $2.37B | $2.37B | $2.36B | $2.36B |
| Retained Earnings | -$2.29B | -$2.33B | -$2.35B | -$2.34B | -$2.34B |
| Gains/Losses Not Affecting Retained Earnings | -$87,000.00 | -$29,000.00 | -$17,000.00 | $7,000.00 | $7,000.00 |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
| Non-Current Deferred Liabilities | – | – | – | $0.00 | $0.00 |
| Convertible preferred securities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $11.88M | -$17.81M | -$43.83M | -$87.83M | -$23.46M |
| Net cash flow from continuing operations | $11.88M | -$17.81M | -$43.83M | -$87.83M | -$23.46M |
| Net Income from Continuing Operations | $35.77M | $20.07M | -$7.93M | -$250.64M | -$23.50M |
| Depreciation & Depletion & Amortization | $1.11M | $1.10M | $1.10M | $3.20M | $1.14M |
| Other Non-Cash Items | $374,000.00 | $361,000.00 | -$1.61M | $146,000.00 | -$453,000.00 |
| Change in Working Capital | -$28.97M | -$42.71M | -$38.03M | $7.36M | -$2.09M |
| -Change in Receivables | -$24.58M | -$45.34M | -$22.34M | -$3.20M | -$3.26M |
| -Change in Inventory | -$2.67M | -$5.79M | -$4.88M | -$9.21M | -$6.26M |
| -Change in Prepaid Assets | -$2.27M | $109,000.00 | -$562,000.00 | -$93,000.00 | $869,000.00 |
| -Change in Payables and Accrued Expense | -$728,000.00 | $6.47M | -$7.89M | $15.64M | $6.80M |
| -Change in Other Current Assets | $74,000.00 | $74,000.00 | $126,000.00 | -$556,000.00 | -$174,000.00 |
| -Change in Other Current Liabilities | -$51,000.00 | -$61,000.00 | -$103,000.00 | $125,000.00 | -$33,000.00 |
| -Change In Other Working Capital | $1.25M | $1.82M | -$2.38M | $4.66M | -$25,000.00 |
| Net cash flow from investing | -$13.97M | $26.69M | $20.97M | -$1.54M | $39.87M |
| Net Cash Flow from Continuing Investing Activities | -$13.97M | $26.69M | $20.97M | -$1.54M | $39.87M |
| Net PPE Purchase and Sale | -$435,000.00 | -$392,000.00 | -$258,000.00 | -$2.00M | -$18,000.00 |
| Net Investment Purchase and Sale | -$13.54M | $27.08M | $21.23M | $460,000.00 | $39.88M |
| Financing Cash Flow | $733,000.00 | -$33,000.00 | $109,000.00 | $90.05M | -$514,000.00 |
| Net Cash Flow from Continuing Financing Activities | $733,000.00 | -$33,000.00 | $109,000.00 | $90.05M | -$514,000.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | -$1.66M | $0.00 |
| Proceeds from Stock Option Exercised | $944,000.00 | $1.32M | $255,000.00 | $1.20M | $140,000.00 |
| Net Other Financing Charges | -$211,000.00 | -$1.35M | -$146,000.00 | -$1.78M | $537,000.00 |
| Ending Cash Balance | $14.96M | $16.33M | $7.48M | $30.23M | $30.23M |
| Net Change in Cash | -$1.36M | $8.85M | -$22.75M | $682,000.00 | $15.89M |
| Beginning Cash Balance | $16.33M | $7.48M | $30.23M | $29.52M | $14.32M |
| Effect of Exchange Rate Changes | -$12,000.00 | $1,000.00 | -$3,000.00 | $35,000.00 | $20,000.00 |
| Free Cash Flow | $11.45M | -$18.20M | -$44.09M | -$89.83M | -$23.48M |
| Gain/Loss from Continuing Operations | – | – | – | $139.54M | $0.00 |
| Deferred Tax | – | – | – | $0.00 | $0.00 |
| Net Issuance Payments Of Debt | – | – | – | $92.82M | -$654,000.00 |
| Net Preferred Stock Issuance | – | – | – | -$537,000.00 | – |
No comments yet — be the first to weigh in on PGEN.
Sign in to join the discussion.